Expertise in
15
conditions

Mariacristina C. Scoto

UCL Queen Square Institute Of Neurology, 
London, ENG, GB 
Expertise in
15
conditions
UCL Queen Square Institute Of Neurology, 
London, ENG, GB 

Overview

Mariacristina Scoto practices practicing medicine in London, United Kingdom.

Ms. Scoto is highly rated in 15 conditions, according to our data. Her clinical expertise encompasses Spinal Muscular Atrophy (SMA), Primary Lateral Sclerosis, Muscle Atrophy, Spinal Muscular Atrophy Type 1, and Gastrostomy.

She is actively involved in clinical research, co-authoring 92 peer reviewed articles and participating in 2 clinical trials.

Gender

Female

Locations

UCL Queen Square Institute Of Neurology, London, ENG, United Kingdom

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Randomised, Double Blind, Placebo Controlled, Multicentre Study to Evaluate the Efficacy and Safety of Givinostat in Ambulant Patients With Duchenne Muscular Dystrophy
Randomised, Double Blind, Placebo Controlled, Multicentre Study to Evaluate the Efficacy and Safety of Givinostat in Ambulant Patients With Duchenne Muscular Dystrophy
Enrollment Status: Completed
Publish Date: February 02, 2023
Intervention Type: Drug
Study Drug: Givinostat
Study Phase: Phase 3
A Randomized, Double-Blind, Placebo-Controlled, Global Phase 3 Study of Edasalonexent in Pediatric Patients With Duchenne Muscular Dystrophy
A Randomized, Double-Blind, Placebo-Controlled, Global Phase 3 Study of Edasalonexent in Pediatric Patients With Duchenne Muscular Dystrophy
Enrollment Status: Completed
Publish Date: June 21, 2022
Intervention Type: Drug
Study Phase: Phase 3
View 1 Less Clinical Trial

92 Total Publications

Evidence no longer matters: newborn screening in England.
Evidence no longer matters: newborn screening in England.
Journal: Lancet (London, England)
Published: July 29, 2026

Frequently Asked Questions about Mariacristina C. Scoto

Is Mariacristina C. Scoto a top-rated expert for Spinal Muscular Atrophy (SMA)?

MediFind is an objective health platform that identifies experts based on real-world data. Mariacristina C. Scoto is classified as an Elite expert for Spinal Muscular Atrophy (SMA), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Mariacristina C. Scoto participate in research or clinical trials?

Yes. Mariacristina C. Scoto has published 92 articles and abstracts on conditions like Spinal Muscular Atrophy (SMA). You can view a list of Mariacristina C. Scoto's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Scoto's expertise for a condition
ConditionClose
View All 9 Advanced Conditions
View All 8 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile